SYNTHESIS Expansion: Design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke

International Journal of Stroke

Volumn 6, Issue 3, 2011, Pages 259-265

  Ciccone, Alfonso ^a   Valvassori, Luca ^a   Nichelatti, Michele ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Catheter based treatment; Cerebral infarction; Cerebrovascular accident; Clinical trials; Endovascular treatment; Interventional radiology; Intra arterial alteplase; Intravenous alteplase; Randomized controlled trial; Stroke

Indexed keywords

ALTEPLASE; HEPARIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG FATALITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); NEUROLOGICAL COMPLICATION; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; STROKE PATIENT; STUDY DESIGN; SURVIVOR;

ANESTHESIA; ANGIOGRAPHY; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CONSTRICTION, PATHOLOGIC; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ENDOVASCULAR PROCEDURES; FOLLOW-UP STUDIES; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MONITORING, PHYSIOLOGIC; PLASMINOGEN ACTIVATORS; SAMPLE SIZE; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79955750550     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00587.x     Document Type: Article

References (21)

1. Wahlgren N, Ahmed N, Dávalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-82.
2. del Zoppo GJ, Poeck K, Pessin MS et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:78-86.
3. Mazighi M, Serfaty JM, Labreuche J et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009; 8:802-9.
4. Endo S, Kuwayama N, Hirashima Y, Akai T, Nishijima M, Takaku A. Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. Am J Neuroradiol 1998; 19:1169-75.
5. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38:948-54.
6. Rabinstein AA, Wijdicks EF, Nichols DA. Complete recovery after early intraarterial recombinant tissue plasminogen activator thrombolysis of carotid T occlusion. Am J Neuroradiol 2002; 23:1596-9.
7. Tomsick T, Brott T, Barsan W et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. Am J Neuroradiol 1996; 17:79-85.
8. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29:4-11.
9. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38:967-73.
10. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282:2003-11.
11. Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38:2633-9.
12. Friedman DP, Maitino AJ. Endovascular interventional neuroradiologic procedures: who is performing them, how often, and where? A survey of academic and nonacademic radiology practices. Am J Neuroradiol 2003; 24:1772-7.
13. Ciccone A, Valvassori L, Gasparotti R, Scomazzoni F, Ballabio E, Sterzi R. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 2007; 38:2191-5.
14. Ciccone A, Valvassori L, Ponzio M et al. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg 2010; 2:74-9.
15. Hacke W, Kaste M, for the ECASS Investigators. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-29.
16. Zijlstra F, Hoorntje JC, de Boer MJ et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341:1413-9.
17. Khatri P, Hill MD, for the IMS III Investigators. et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008; 3:130-7.
18. Valvassori L, Ciccone A, Sterzi R. Response to letter by Nichols et al. Stroke 2008; 39:e72.
19. Candelise L, Pinardi G, Aritzu E, Musicco M. Telephone interview for stroke outcome assessment. Cerebrovasc Dis 1994; 4:341-3.
20. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-7.
21. Mattle HP, Arnold M, Georgiadis D et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008; 39:379-83.